Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.90 Price Target Mar 5, 2026 11:05AM
Emerging Growth Research Issues Flash Update on Immuron Limited, Maintains Buy-Extended Rating and $3.50 Price Target Jan 22, 2026 06:00AM
Emerging Growth Research Initiates Coverage on Immuron Limited with a Buy-Extended Rating and $4.00 Price Target Oct 17, 2025 11:07AM
Immuron Limited to Present at November 21st Virtual Investor Summit Microcap Event Nov 18, 2024 08:30AM
Immuron (IMRN) Plans Phase 2 Trial for IMM-529 following FDA review Sep 5, 2024 11:56AM